Mebendazole Grindeks

Mebendazole, the active ingredient in Mebendazole Grindeks, is a benzimidazole anthelmintic presented as a tablet for oral use. It is used to treat intestinal helminth infections, including roundworm, hookworm, whipworm and pinworm, in both children and adults.

GNH USA supplies Mebendazole Grindeks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing, regulatory support and consistent quality for global health programs. The company adheres to stringent GMP standards and offers flexible packaging options to meet diverse market requirements.

Mebendazole is an anthelmintic drug that targets intestinal helminths, providing therapeutic benefit in several worm infections.

- Ascariasis (roundworm infection): eliminates adult worms and reduces egg shedding, relieving gastrointestinal symptoms. - Hookworm infection (ancylostomiasis): eradicates hookworms, improving anemia and intestinal health. - Trichuriasis (whipworm infection): clears whipworms, alleviating abdominal discomfort and dysentery. - Enterobiasis (pinworm infection): removes pinworms, stopping perianal itching and transmission.

Mebendazole may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal pain: mild stomach discomfort. - Nausea: feeling of queasiness. - Vomiting: occasional emesis. - Diarrhea: loose stools. - Headache: mild cranial pain.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, difficulty breathing. - Hepatotoxicity: elevated liver enzymes or jaundice. - Blood dyscrasias: neutropenia, leukopenia, or thrombocytopenia. - Stevens‑Johnson syndrome: severe skin blistering.

When using Mebendazole, certain safety considerations should be observed to minimise risk.

- Pregnancy: consult a healthcare professional before use, as safety data are limited. - Breastfeeding: weigh potential benefits against possible infant exposure. - Liver disease: use with caution; monitor hepatic function if prolonged therapy is required. - Drug interactions: review concomitant medications for possible interactions. - Pediatric dosing: follow prescriber instructions, especially in children under two years. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Mebendazole can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Cimetidine: may increase mebendazole plasma levels, raising risk of toxicity. - Warfarin: potentiates anticoagulant effect, requiring close INR monitoring. - Antifungal azoles (e.g., ketoconazole): can elevate mebendazole concentrations.

Moderate Interactions (Monitor Closely): - Antacids containing aluminum or magnesium: may reduce absorption of mebendazole. - Oral contraceptives: possible reduction in contraceptive effectiveness; consider additional protection. - Other anthelmintics (e.g., albendazole): concurrent use may increase adverse effect risk.